Africa CDC and PAHO Collaboration: Strengthening Health Access

By Crystal Lubbe

October 30, 2024

The article from the Africa Centres for Disease Control and Prevention (Africa CDC) website, titled “PAHO and Africa CDC strengthen collaboration to address access to essential medicines and vaccines,” emphasises a vital partnership aimed at improving access to essential medicines and vaccines. This collaboration signifies a commitment to enhance health outcomes in both Africa and the Americas.

Africa CDC and PAHO Partnership Agreement

On September 20, 2024, Pan American Health Organization (PAHO) and Africa CDC agreed to collaborate on equitable access to vaccines and health technologies during Africa CDC’s first official visit to PAHO in Washington, D.C.

PAHO and Africa CDC Collaboration Objectives

The partnership prioritises equitable access by enhancing regional regulatory, innovation, and production mechanisms to improve access to essential medicines and vaccines in Africa and the Americas. Furthermore, it aims to enhance regional manufacturing capacities through initiatives like the African Pooled Procurement Mechanism (APPM) and the Partnerships for African Vaccine Manufacturing (PAVM). PAVM aims to empower African vaccine manufacturing to provide over 60% of the continent’s vaccine needs by 2040.

Key Areas of Cooperation

Pooled Procurement Mechanism: PAHO will share its expertise on operationalising regional revolving funds. Therefore, supporting Africa CDC in implementing the APPM. This mechanism is intended to improve access to quality and affordable health products and promote local manufacturing.
Regulatory and Production Strategies: The discussions focused on demand consolidation, planning, quality, and logistics. Further also strengthening regulatory and regional production strategies to improve access to essential medicines.
Research and Innovation: Advancing research, innovation, and digital transformation of health systems to effectively address public health challenges.
Emergency Response: The collaboration will build resilience by improving preparedness and response to health emergencies, including the ongoing Mpox outbreak. Africa CDC briefed PAHO on the Mpox continental response plan, which emphasises access to lifesaving vaccines.

Statements from Leaders

Dr. Jarbas Barbosa, PAHO Director, highlighted the objective of cultivating a more resilient region by enhancing regional manufacturing capabilities. Therefore, ultimately decreasing reliance on global interventions during crucial emergencies. On the other hand, Dr. Jean Kaseya, Africa CDC Director General, emphasised the significance of this partnership in advancing health outcomes through collaborative efforts.

Broader Strategic Priorities

The collaboration seeks to promote broader strategic priorities in both regions, with a focus on improving and safeguarding health. This includes exploring opportunities for south-south cooperation that can address health challenges and capitalize on the strengths of both regions.

In conclusion,this partnership aims to enhance health outcomes, access to essential products, and strengthen health systems in Africa and the Americas. The commitment to addressing access to essential medicines and vaccines reflects a strategic approach to global health collaboration.

Reference url

Recent Posts

prior authorization reforms
     

Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR

🚀 Are prior authorizations stalling care delivery in the U.S. healthcare system?

The HHS has launched an ambitious collaboration with major insurers to reform prior authorization processes across Medicare Advantage, Medicaid, and commercial plans. With a goal to standardize submissions by 2027 and significantly reduce requirements by 2026, this initiative promises to accelerate care decisions and enhance transparency.

Dive into the details of these pivotal reforms and discover their potential to streamline healthcare and improve patient outcomes.

#SyenzaNews #HealthcareInnovation #healthcare #healthcarepolicy

private health funding
    

Private Health Funding Under South Africa’s National Health Insurance Act

🚀 Update on NHI in South Africa.

In their insightful article, Solanki et al. discuss the complexities of private health funding amidst the nation’s National Health Insurance Act. They discuss two key scenarios: a passive approach that risks the sustainability of the private sector and an active reform strategy that could ensure a smoother transition to universal coverage.

Curious about how these strategies could reshape healthcare access and costs in South Africa? Don’t miss out on this critical analysis!

#SyenzaNews #HealthEconomics #HealthcarePolicy

drug price transparency
     

Impending Net Drug Price Transparency Regulation in the U.S.

💡 Are you ready for a potential game-changer in drug pricing transparency?

CMS Administrator Mehmet Oz has hinted at a new rule aimed at enforcing stricter disclosures for drug prices, requiring healthcare companies to reveal actual transaction costs. This could reshape how price transparency is managed across the industry and challenge pharmacy benefit managers to rethink rebate practices.

Curious about how this will impact healthcare economics and what it means for drug affordability? Dive into the article for all the insights!

#SyenzaNews #healthcare #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.